Skip to content
10-Q

Quarterly Report

NEXIEN BIOPHARMA, INC.

0001493152-25-006734

← back to feed
Filed
Feb 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Feb 14, 2025 70.77M sh
Shares Diluted Q2 2025 · Dec 31, 2024 70.77M sh
Shares Diluted Q2 2025 · Dec 31, 2024 70.62M sh
Shares Diluted Q2 2025 · Dec 31, 2023 65.11M sh
Shares Diluted Q2 2025 · Dec 31, 2023 64.84M sh
Operating Cash Flow Q2 2025 · Dec 31, 2024 −$37.88K
Operating Cash Flow Q2 2025 · Dec 31, 2023 −$32.53K
Cash And Equivalents Q2 2025 · Dec 31, 2024 $1.31K
Cash And Equivalents Q2 2025 · Jun 30, 2024 $4.18K
Stockholders Equity Q2 2025 · Dec 31, 2024 −$422.69K
Stockholders Equity Q2 2025 · Sep 30, 2024 −$391.75K
Stockholders Equity Q2 2025 · Jun 30, 2024 −$361.25K
Stockholders Equity Q2 2025 · Dec 31, 2023 −$314.19K
Stockholders Equity Q2 2025 · Sep 30, 2023 −$290.8K
Stockholders Equity Q2 2025 · Jun 30, 2023 −$252.01K
Current Liabilities Q2 2025 · Dec 31, 2024 $424K
Current Liabilities Q2 2025 · Jun 30, 2024 $365.43K
Total Liabilities Q2 2025 · Dec 31, 2024 $424K
Total Liabilities Q2 2025 · Jun 30, 2024 $365.43K
Current Assets Q2 2025 · Dec 31, 2024 $1.31K
Current Assets Q2 2025 · Jun 30, 2024 $4.18K
Total Assets Q2 2025 · Dec 31, 2024 $1.31K
Total Assets Q2 2025 · Jun 30, 2024 $4.18K
Eps Diluted Q2 2025 · Dec 31, 2024 $0.00
Eps Diluted Q2 2025 · Dec 31, 2024 $0.00
Eps Diluted Q2 2025 · Dec 31, 2023 $0.00
Eps Diluted Q2 2025 · Dec 31, 2023 $0.00
Eps Basic Q2 2025 · Dec 31, 2024 $0.00
Eps Basic Q2 2025 · Dec 31, 2024 $0.00
Eps Basic Q2 2025 · Dec 31, 2023 $0.00
Eps Basic Q2 2025 · Dec 31, 2023 $0.00
Sga Expense Q2 2025 · Dec 31, 2024 $8.01K
Sga Expense Q2 2025 · Dec 31, 2024 $11.04K
Sga Expense Q2 2025 · Dec 31, 2023 $7.81K
Sga Expense Q2 2025 · Dec 31, 2023 $54.27K
Rd Expense Q2 2025 · Dec 31, 2024 $0
Rd Expense Q2 2025 · Dec 31, 2024 $0
Rd Expense Q2 2025 · Dec 31, 2023 $0
Rd Expense Q2 2025 · Dec 31, 2023 $0
Net Income Q2 2025 · Dec 31, 2024 −$39.47K
Net Income Q2 2025 · Dec 31, 2024 −$71.48K
Net Income Q2 2025 · Sep 30, 2024 −$32K
Net Income Q2 2025 · Dec 31, 2023 −$24.52K
Net Income Q2 2025 · Dec 31, 2023 −$99.44K
Net Income Q2 2025 · Sep 30, 2023 −$74.92K
Operating Income Q2 2025 · Dec 31, 2024 −$11.61M